FUTUREsynthesis in June this year participated in the meeting of the consortium involved in the project “AI-enabled RNA nanotechnology DElivery SysTem for INformATION transfer into cells.” H2020-FETOPEN-2018-2019-2020-01 Horizon 2020 (DESTINATION) 2021, which was held in Rome, Italy.
The project deals with the interdisciplinary combination of AI/machine learning fields with RNA nanotechnology, biochemistry and advanced imaging methods. DESTINATION aims to create a first-generation RNA delivery platform (RNano) for efficient delivery of information, such as mRNA, to cells in vivo. DESTINATION will generate an intelligent library of (a) programmable RNano scaffolds for attachment of packaged mRNA and (b) RNA aptamers for laser-specific internalization of RNanos into cells.
DESTINATION, a multi-disciplinary consortium of top scientists, R&D companies, including FUTUREsynthesis, will enhance the impact of the DESTINATION project by developing a strategy focused on securing early engagement with investors, regulators, potential manufacturing and industrial partners.
Together, DESTINATION will strengthen the EU’s position in the emerging fields of RNA technology.
